PISCATAWAY, N.J., Dec. 10, 2020 /PRNewswire/ -- MSN Labs, based in Hyderabad India, recently received FDA approval to market their generic versions of Toremifene 60mg tablets, (AB rated to Kyowa Kirin's Fareston©) & Aminocaproic Acid 500mg tablet, (AB rated Clover's Amicar©) under the Novadoz label. Novadoz is the U.S sales and marketing affiliate for MSN's portfolio of finished dosage forms. The company has commenced shipping of Toremifene, with Aminocaproic Acid to begin shortly.
MSN `s Generic Toremifene Citrate Receives Tentative Approval In US
Eirgen Pharma's Generic Toremifene Citrate Receives Approval in US